All companies
Visit website
BioCertica
OperatingBioCertica, Inc.
Healthcare · Biotech · Founded 2020
Personalized shopping experience for wellness customers using AI
Valuation cap ⓘ
$9.0M
As of Aug 2023 · from BioCertica Crowd SAFE 1 · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$25,021
Across 1 round since 2023
Latest share price
$1.00
BioCertica Crowd SAFE 1 offering price
Financials
FY2021–FY2024 · from SEC filings · hover any figure for its source$193K
−$200K
2021
$181K
−$686K
2022
$181K
−$664K
2023
$140K
−$334K
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2021
FY2022
FY2023
FY2024
Income statement
Revenue
$192,828
$180,841
$180,841
$139,926
Cost of goods sold
$228,861
$420,788
$420,788
$131,516
Gross margin
-19%
-133%
-133%
6%
Net income
-$200,342
-$685,525
-$663,703
-$334,131
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$37,478
$1,252
$1,252
$342
Accounts receivable
$1,625
$4,601
$4,601
$3,567
Total assets
$183,545
$289,456
$769,918
$693,830
Short-term debt
$83,019
$791,194
$791,194
$947,712
Long-term debt
$55,788
$0
$0
$5,539
Total liabilities
$138,807
$791,194
$791,194
$953,251
Other
Headcount
—
30
—
16
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$9.0M
Valuation cap
BioCertica Crowd SAFE 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $25K / $1.2MInvestors 48Valuation cap $9M
Reg CF annual-report compliance
Not requiredFewer than 300 holders of record
Filed 1 of 3 annual reports (FY2023–FY2025)
48 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001972790Share price $1.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.